Company intelligence / Profile preview

Sixty Degree Capital

Toronto, Ontario, Canadasixtydegreecapital.com ↗

Ownership: Private
Development stage: Other

Overview

Sixty Degree Capital is an active North American multi-stage venture capital firm investing in high-growth technology and healthcare companies—including biotech and therapeutics—across Series A to pre-IPO stages. The firm recently closed its third fund at $250M and has invested in notable healthcare and biotech ventures[1][4][5].

Industry: Investors

Partnerships

Portfolio includes partnerships with leading investors and co-investors such as Leaps by Bayer and Sanofi Ventures through portfolio company financings[6].

Beyond the preview

Go deeper on Sixty Degree Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sixty Degree Capital.

Explore the full profile